OQROGet OQRO Pro
Insider trade

Zenas Biopharma (ZBIO)CEO bought ~$269K

Leon O Jr Moulder, CEO at Zenas Biopharma, bought ~$269K of Zenas Biopharma shares.

~$269K
Approx. value · 25K sh @ $10.76
196K
Holds after · shares reported
Traded
Dec 3, 2024
Filed
Dec 5, 2024

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Nov 18, 2024InsiderCEO purchased ~$113K of ZBIO shares in the open market
  2. Nov 19, 2024InsiderCEO purchased ~$36K of ZBIO shares in the open market
  3. Dec 3, 2024 · this disclosureInsiderCEO purchased ~$269K of ZBIO shares in the open market

What came next

  1. Dec 4, 2024InsiderCEO purchased ~$449K of ZBIO shares in the open market
  2. Feb 18, 2025InsiderCEO purchased ~$167K of ZBIO shares in the open market
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Zenas Biopharma

OQRO holds no insider, Congress, fund or contract record for Zenas Biopharma dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ZBIO page.

Other recent filings by Leon O Jr Moulder, Chief Executive Officer

The full history of Leon O Jr Moulder, Chief Executive Officer is on the profile page.

How this filing works

Other disclosures at Zenas Biopharma

Everything OQRO holds on this company is on its ZBIO page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data